Subjects | NAF+ women | P | |
---|---|---|---|
 | Proportion | % |  |
Women <50 years old (n = 22) | Â | Â | Â |
No risk reduction | 11/12 | 92 | Â |
Risk reduction | 1/10 | 10 | 0.0003 |
BRCA - | 10/12 | 83 | Â |
BRCA + | 2/10 | 20 | 0.008 |
   BRCA- women (n = 12) |  |  |  |
No risk reduction | 9/9 | 100 | Â |
Risk reduction | 1/3 | 33 | 0.045 |
   BRCA+ women (n = 10) |  |  |  |
No risk reduction | 2/3 | 66 | Â |
Risk reduction | 0/7 | 0 | 0.07 |
Women ≥50 years old (n = 21) |  |  |  |
No risk reduction | 6/7 | 86 | Â |
Risk reduction | 4/14 | 29 | 0.02 |
BRCA - | 9/14 | 64 | Â |
BRCA + | 1/7 | 14 | 0.06 |
   BRCA- women (n = 14) |  |  |  |
No risk reduction | 6/6 | 100 | Â |
Risk reduction | 3/8 | 38 | 0.03 |
   BRCA+ women (n = 7) |  |  |  |
No risk reduction | 0/1 | 0 | Â |
Risk reduction | 1/6 | 17 | 1.000 |